open access

Vol 72, No 4 (2021)
Clinical vignette
Submitted: 2021-04-13
Accepted: 2021-04-29
Early publication date: 2021-05-17
Get Citation

Clinical challenges and dilemmas in the management of advanced pancreatic neuroendocrine tumour — the first manifestation of von Hippel-Lindau disease in a young patient

Karolina Morawiec-Sławek1, Marta Opalińska2, Agnieszka Stefańska2, Anna Sowa-Staszczak1, Alicja Hubalewska-Dydejczyk1
DOI: 10.5603/EP.a2021.0052
·
Pubmed: 34010452
·
Endokrynol Pol 2021;72(4):412-413.
Affiliations
  1. Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
  2. Chair and Department of Endocrinology, University Hospital, Krakow, Poland

open access

Vol 72, No 4 (2021)
Clinical Vignette
Submitted: 2021-04-13
Accepted: 2021-04-29
Early publication date: 2021-05-17

Abstract

Not required for Clinical Vignette.

Abstract

Not required for Clinical Vignette.

Get Citation

Keywords

pNET; von Hippel-Lindau disease; somatostatin analogues

About this article
Title

Clinical challenges and dilemmas in the management of advanced pancreatic neuroendocrine tumour — the first manifestation of von Hippel-Lindau disease in a young patient

Journal

Endokrynologia Polska

Issue

Vol 72, No 4 (2021)

Article type

Clinical vignette

Pages

412-413

Early publication date

2021-05-17

Page views

598

Article views/downloads

198

DOI

10.5603/EP.a2021.0052

Pubmed

34010452

Bibliographic record

Endokrynol Pol 2021;72(4):412-413.

Keywords

pNET
von Hippel-Lindau disease
somatostatin analogues

Authors

Karolina Morawiec-Sławek
Marta Opalińska
Agnieszka Stefańska
Anna Sowa-Staszczak
Alicja Hubalewska-Dydejczyk

References (5)
  1. Kos-Kudła B, Hubalewska-Dydejczyk A, Kuśnierz K, et al. Consensus Conference, olish Network of Neuroendocrine Tumours. Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol. 2013; 64(6): 459–479.
  2. Krauss T, Ferrara AM, Links TP, et al. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors. Endocr Relat Cancer. 2018; 25(9): 783–793.
  3. Falconi M, Eriksson B, Kaltsas G, et al. Vienna Consensus Conference participants. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 2016; 103(2): 153–171.
  4. Ahmad S, Naber MR, Giles RH, et al. Diagnostic and management strategies for pNETs in Von Hippel-Lindau: a systematic review. Endocr Relat Cancer. 2021; 28(3): 151–160.
  5. Stueven AK, Kayser A, Wetz C, et al. Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future. Int J Mol Sci. 2019; 20(12).

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl